Abstract

This paper displays the potential of an in-line PAT system for early phase product development during pharmaceutical continuous manufacturing following a Quality by Design (QbD) framework. Hot melt extrusion (HME) is used as continuous manufacturing process and UV–Vis spectroscopy as an in-line monitoring system. A sequential design of experiments (DoE) (screening, optimisation and verification) was used to gain process understanding for the manufacture of piroxicam (PRX)/Kollidon® VA64 amorphous solid dispersions. The influence of die temperature, screw speed, solid feed rate and PRX concentration on the critical quality attributes (CQAs) absorbance and lightness of color (L*) of the extrudates was investigated using multivariate tools. Statistical analysis results show interaction effects between concentration and temperature on absorbance and L* values. Solid feed rate has a significant effect on absorbance only and screw speed showed least impact on both responses for the screening design. The optimum HME process conditions were confirmed by 4 independent studies to be 20% w/w of PRX, temperature 140 °C, screw speed 200 rpm and feed rate 6 g/min. The in-line UV-Vis system was used to assess the solubility of PRX in Kollidon® VA64 by measuring absorbance and L* values from 230 to 700 nm. Oversaturation was observed for PRX concentrations higher than 20% w/w. Oversaturation can be readily identified as it causes scattering in the visible range. This is observed by a shift of the baseline in the visible part of the spectrum. Extrudate samples were analyzed for degradation using off-line High-Performance Liquid Chromatography (HPLC) standard methods. Results from off-line experiments using differential scanning calorimetry (DSC), and X-ray diffraction (XRD) are also presented.

Highlights

  • The research presented here adopts and evaluates the sequential experimental design methodology using in-line monitoring system based on UV-Vis spectroscopy for early phase product development

  • The results reported here showed that UV-Vis is a robust and rapid Process Analytical Technology (PAT) system that can be used to identify the relationship between critical process parameters (CPPs) and critical quality attributes (CQAs) in hot melt extrusion (HME) processes using multivariate approach

  • In-line UV-Vis spectroscopy was used as a fast-working PAT tool for early phase product development during HME

Read more

Summary

Introduction

The research presented here adopts and evaluates the sequential experimental design methodology using in-line monitoring system based on UV-Vis spectroscopy for early phase product development. In-line sampling is the method of choice for FDA-conforming Process Analytical Technology (PAT) standards. Optical spectroscopy has shown to be a suitable in-line technique for hot melt extrusion (HME). The techniques allow non-invasive sampling without interrupting continuous processing [1]. Pharmaceutical HME as a continuous manufacturing (CM) system deserves considerable attention. In the last 10 years, nearly 400 research papers or reviews have been published on CM of pharmaceutical hot melt extrusion (HME) processes, compared to only 60 between 1997 and 2007. Acceptance of continuous manufacturing in the regulatory world helps to pave the way for CM [2]. In April 2016, Janssen Supply Chain (JSC), a division of Johnson & Johnson (J&J), received the first approval to switch from batch to continuous processing for the HIV-1 treatment Prezista® (darunavir) [4]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call